Do Not Skip Levothyroxine for Two Days When TSH Is Low

If your TSH is low while taking levothyroxine, do not skip doses for two days. Instead, reduce your daily dose by 12.5–25 µg and recheck TSH in 4–8 weeks to guide further adjustment. 1, 2 Skipping doses creates erratic hormone levels and does not provide the controlled, gradual correction needed to safely restore TSH to the target range.

Why Skipping Doses Is Not Recommended

Levothyroxine Has a Long Half-Life

Levothyroxine has a half-life of approximately 7 days, meaning it takes weeks—not days—for serum levels to reach a new steady state after any dose change. 1, 2
Skipping two doses will not meaningfully lower your steady-state thyroid hormone level but will create temporary fluctuations that make it harder to interpret follow-up TSH results. 1

Erratic Dosing Complicates Monitoring

TSH takes 4–8 weeks to equilibrate after a change in levothyroxine dose; skipping doses introduces variability that prevents accurate assessment of your true replacement need. 1, 2, 3
Intermittent dosing makes it impossible to distinguish whether a subsequent TSH change reflects the skipped doses, your baseline requirement, or both. 1

Guideline-Based Dose Adjustment Is Safer

The American College of Endocrinology and the American Association of Clinical Endocrinologists recommend reducing the daily dose by 12.5–25 µg when TSH is suppressed, then rechecking TSH in 4–8 weeks. 1, 2, 4
This approach provides a controlled, predictable reduction in thyroid hormone exposure without the peaks and troughs caused by skipping doses. 1, 2

Risks of a Low TSH (Subclinical Hyperthyroidism from Overtreatment)

Cardiovascular Consequences

TSH suppression below 0.1 mIU/L is associated with increased all-cause mortality, atrial fibrillation, and cardiovascular events, especially in older adults. 1, 4, 3, 5
Even mild TSH suppression (0.1–0.45 mIU/L) may increase cardiovascular risk, although the evidence is less robust than for TSH <0.1 mIU/L. 4
The FDA label for levothyroxine explicitly warns that overtreatment may precipitate angina or arrhythmias, particularly in patients with underlying cardiovascular disease and in the elderly. 3

Skeletal Consequences

Chronic TSH suppression accelerates bone loss and raises fracture risk in postmenopausal women, even when free T4 remains within the normal range. 1, 4, 3
The FDA label notes that increased bone resorption and decreased bone mineral density occur as a result of levothyroxine over-replacement. 3

Prevalence of Overtreatment

Approximately 20% of patients on levothyroxine are overtreated, a condition that substantially raises the risk of these adverse events. 1, 4

The Correct Approach: Gradual Dose Reduction

Step 1: Reduce the Daily Dose

Decrease your levothyroxine by 12.5–25 µg per day to allow TSH to rise toward the target range of 0.45–4.12 mIU/L. 1, 2, 4
For example, if you are taking 100 µg daily, reduce to 87.5 µg (by alternating 100 µg and 75 µg on alternate days) or to 75 µg daily, depending on the degree of TSH suppression. 1, 2

Step 2: Recheck TSH in 4–8 Weeks

Measure TSH 4–8 weeks after the dose reduction to assess the new steady-state level. 1, 2, 3
If TSH remains suppressed, make another 12.5–25 µg reduction and recheck in another 4–8 weeks. 1, 2

Step 3: Continue Adjustments Until TSH Is in Range

Repeat this cycle of dose reduction and TSH monitoring until TSH is within the target range of 0.45–4.12 mIU/L. 1, 2, 4
Once TSH is stable in the target range, monitor every 6 months initially, then annually. 1, 2, 4

Special Considerations

Verify the Original Indication for Levothyroxine

Before reducing the dose, confirm why you were started on levothyroxine. 4
If you have thyroid cancer or thyroid nodules, intentional TSH suppression may be therapeutic; dose adjustments should be coordinated with your endocrinologist. 4, 3
If you were treated for primary hypothyroidism without nodules or cancer, TSH should be maintained within the full reference range (0.45–4.12 mIU/L). 1, 4

Elderly Patients and Those with Cardiac Disease

Older adults and patients with coronary artery disease are at particularly high risk for atrial fibrillation and other cardiovascular events from TSH suppression. 1, 4, 3, 5
In these populations, even mild TSH suppression (0.1–0.45 mIU/L) warrants dose reduction. 4

Do Not Wait for Symptoms of Hyperthyroidism

Subclinical overtreatment (low TSH with normal free T4) already confers cardiovascular and skeletal harm, even in the absence of overt hyperthyroid symptoms such as tremor, palpitations, or heat intolerance. 4
Dose reduction should not be delayed until symptoms appear. 4

Common Pitfalls to Avoid

Do Not Assume a Low TSH Is Acceptable Because Free T4 Is Normal

A suppressed TSH with normal free T4 still indicates overtreatment and carries significant cardiovascular and skeletal risks. 4
The target for levothyroxine replacement in primary hypothyroidism is a TSH within the reference range (0.45–4.12 mIU/L), not simply a normal free T4. 1, 4

Do Not Skip Doses as a Substitute for Dose Reduction

Skipping doses creates erratic hormone levels and does not provide the controlled, gradual correction needed to safely restore TSH to the target range. 1, 2
The long half-life of levothyroxine means that steady-state levels take weeks to change, so intermittent dosing is ineffective and complicates monitoring. 1, 2

Verify Adherence Before Assuming Overtreatment

Non-compliance is the most common cause of erratic TSH values. 1, 4
If you have been taking your levothyroxine inconsistently, a single low TSH may not reflect true overtreatment; however, if you have been adherent and TSH is persistently suppressed, dose reduction is warranted. 1, 4

Summary Algorithm

Confirm adherence: Verify that you have been taking levothyroxine consistently. 1, 4
Verify the indication: Confirm whether TSH suppression is intentional (e.g., thyroid cancer) or unintentional (overtreatment of hypothyroidism). 4
Reduce the daily dose by 12.5–25 µg if TSH is suppressed and you are being treated for primary hypothyroidism. 1, 2, 4
Recheck TSH in 4–8 weeks to assess the new steady-state level. 1, 2, 3
Repeat dose adjustments every 4–8 weeks until TSH is within the target range of 0.45–4.12 mIU/L. 1, 2, 4
Monitor TSH every 6 months initially, then annually once stable. 1, 2, 4

If my TSH is low, should I skip my levothyroxine (thyroid hormone replacement) for two days?

Have a follow-up question?